HW
REGN icon

Hancock Whitney’s Regeneron Pharmaceuticals REGN Stock Holding History

Hancock Whitney’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$494K Hold
792
– – 0.01% 575
2026
Q1 		$560K Sell
792
-9
-1% -$6.89K 0.01% 544
2025
Q4 		$618K Sell
801
-429
-35% -$291K 0.01% 510
2025
Q3 		$692K Sell
1,230
-20
-2% -$11.3K 0.01% 495
2025
Q2 		$656K Sell
1,250
-514
-29% -$287K 0.01% 503
2025
Q1 		$1.12M Sell
1,764
-5,650
-76% -$3.89M 0.04% 293
2024
Q4 		$5.28M Sell
7,414
-355
-5% -$298K 0.17% 99
2024
Q3 		$8.17M Sell
7,769
-36
-0.5% -$40.1K 0.26% 83
2024
Q2 		$8.2M Sell
7,805
-74
-0.9% -$71.7K 0.28% 80
2024
Q1 		$7.58M Buy
7,879
+278
+4% +$264K 0.26% 90
2023
Q4 		$6.68M Sell
7,601
-54
-0.7% -$44.5K 0.25% 89
2023
Q3 		$6.3M Buy
7,655
+134
+2% +$105K 0.26% 87
2023
Q2 		$5.4M Sell
7,521
-716
-9% -$552K 0.21% 99
2023
Q1 		$6.77M Sell
8,237
-709
-8% -$535K 0.27% 86
2022
Q4 		$6.45M Buy
8,946
+200
+2% +$148K 0.25% 89
2022
Q3 		$6.03M Buy
+8,746
New +$5.5M 0.26% 84
2021
Q1 		– Sell
-1,424
Closed -$688K – 813
2020
Q4 		$688K Sell
1,424
-58
-4% -$31.3K 0.02% 451
2020
Q3 		$830K Sell
1,482
-4
-0.3% -$2.42K 0.03% 403
2020
Q2 		$927K Sell
1,486
-10,755
-88% -$6.1M 0.04% 383
2020
Q1 		$5.98M Sell
12,241
-4,113
-25% -$1.7M 0.23% 114
2019
Q4 		$6.14M Sell
16,354
-10,020
-38% -$3.37M 0.2% 139
2019
Q3 		$7.32M Sell
26,374
-1,330
-5% -$394K 0.24% 115
2019
Q2 		$8.67M Sell
27,704
-571
-2% -$190K 0.28% 103
2019
Q1 		$11.6M Buy
28,275
+6,851
+32% +$2.82M 0.37% 73
2018
Q4 		$8M Sell
21,424
-9,360
-30% -$3.43M 0.27% 106
2018
Q3 		$12.4M Buy
+30,784
New +$11.7M 0.35% 84

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Hancock Whitney's REGN Position: Q2 2026 in Review

Hancock Whitney held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 792 shares worth $494K. The position accounts for 0.01% of the portfolio, ranked #575.

Hancock Whitney first reported a position in REGN in Q3 2018 and has held it in 26 quarters since. The position peaked at $12.4M in Q3 2018. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Hancock Whitney held 792 shares of Regeneron Pharmaceuticals worth $494K as of Q2 2026.
  • Hancock Whitney left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.01% of Hancock Whitney's portfolio in Q2 2026, its #575 holding.
  • Hancock Whitney first reported a position in Regeneron Pharmaceuticals in Q3 2018 and has held it in 26 quarters since.
  • Hancock Whitney's Regeneron Pharmaceuticals position peaked at $12.4M in Q3 2018.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Hancock Whitney's 13F filing for Q2 2026, filed 14 Aug 2026.